Table 3 Synopsis of baseline characteristics and clinical outcomes of patients with NNRTI PDR
No | Baseline characteristics | Clinical outcomes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ART start date | Age | Sex | WHO stage | CD4 count | Viral load | NNRTI DRM | VL 6mo | Last known VL | Treatment outcome | Last known ART regimen | Status date | |
1 | 13.10.2014 | 36 | Female | 1 | 493 | 17,539 | K103N | 636 | 27,000 | AliveOnART | 3TC/ZDV/ATV/r | 31.10.2019 |
2 | 07.10.2014 | 41 | Female | 2 | na | 84,598 | K103N, V106M | 40 | 40 | AliveOnART | 3TC/TDF/EFV | 31.10.2019 |
3 | 13.11.2014 | 25 | Female | 2 | na | 86,861 | Y181C | 110,384 | 110,384 | Defaulted | 3TC/TDF/EFV | 07.10.2015 |
4 | 11.09.2014 | 46 | Female | 1 | 56 | na | K103N | 40 | 40 | AliveOnART | 3TC/TDF/DTG | 31.10.2019 |
5 | 17.09.2014 | 42 | Male | 2 | 123 | 5765 | V108I, Y181C, H221Y, M184V | 40 | 489 | AliveOnART | 3TC/TDF/DTG | 31.10.2019 |
6 | 08.10.2014 | 36 | Female | 3 | 16 | 224,736 | K103N, V138Q, Y181C | na | 224,736 | Died | 3TC/TDF/EFV | 27.01.2015 |
7 | 13.10.2014 | 32 | Female | 1 | 92 | 37,507 | V179D | na | 150 | Defaulted | 3TC/TDF/EFV | 08.06.2017 |
8 | 14.10.2014 | 51 | Male | 1 | na | 377,623 | E138K | na | 377,623 | Defaulted | 3TC/TDF/EFV | 12.01.2015 |
9 | 05.11.2014 | 33 | Female | 3 | na | 121,761 | K103N | na | 121,761 | Died | 3TC/TDF/EFV | 06.12.2014 |
10 | 11.11.2014 | 42 | Male | 1 | 380 | 35,529 | V108I, Y181C, H221Y | 40 | 40 | AliveOnART | 3TC/TDF/EFV | 31.10.2019 |
11 | 20.11.2014 | 60 | Male | 3 | 49 | 800,810 | Y181C, H221Y | 40 | 40 | Defaulted | 3TC/ZDV/ATV/r | 10.09.2019 |
12 | 02.12.2014 | 31 | Male | 1 | 294 | 8117 | K103N | 40 | 40 | Defaulted | 3TC/TDF/EFV | 11.03.2016 |
13 | 15.05.2015 | 32 | Female | 1 | 477 | 16,293 | K238T | 40 | 40 | AliveOnART | 3TC/TDF/DTG | 31.10.2019 |
14 | 06.05.2015 | 25 | Female | 1 | 456 | 14,946 | K103N, A98G, V108I | 40 | 40 | Defaulted | 3TC/TDF/EFV | 22.12.2018 |
15 | 28.05.2015 | 23 | Female | 2 | 406 | 1,824,545 | K103N | 40 | 40 | Defaulted | 3TC/TDF/EFV | 17.04.2017 |
16 | 11.05.2015 | 40 | Female | 1 | 163 | 45,245 | E138G | 40 | 40 | AliveOnART | 3TC/TDF/DTG | 31.10.2019 |
17 | 10.11.2014 | 29 | Female | 2 | 183 | 708,905 | V108I, Y181C, H221Y | na | 708,905 | TransferOut | 3TC/TDF/EFV | 13.05.2015 |
18 | 18.05.2015 | 34 | Female | 1 | 44 | 204,902 | E138G | 7936 | 150 | Defaulted | 3TC/ZDV/ATV/r | 27.05.2018 |
19 | 21.05.2015 | 22 | Female | 1 | 87 | 243,509 | V106M, V179D | na | 243,509 | Defaulted | 3TC/TDF/EFV | 16.09.2015 |
20 | 20.05.2015 | 28 | Female | 3 | na | 329,391 | G190A | na | 40 | TransferOut | 3TC/TDF/EFV | 19.03.2017 |
21 | 22.05.2015 | 30 | Male | 1 | 376 | 507,147 | K103N | 40 | 40 | AliveOnART | 3TC/TDF/DTG | 31.10.2019 |
22 | 28.05.2015 | 29 | Female | 1 | 230 | 2,091,728 | A98G, E138A | 40 | 150 | AliveOnART | 3TC/TDF/DTG | 31.10.2019 |
23 | 27.05.2015 | 25 | Female | 1 | 411 | 1,546,355 | K103S, G190A | 40 | 40 | Defaulted | 3TC/TDF/EFV | 01.09.2019 |
24 | 01.06.2015 | 26 | Female | 1 | 209 | 990,009 | K103N | na | 990,009 | Defaulted | 3TC/TDF/EFV | 03.11.2015 |
25 | 04.06.2015 | 43 | Male | 1 | 294 | 529,513 | Y181C | na | 40 | AliveOnART | 3TC/TDF/DTG | 31.10.2019 |
26 | 23.06.2015 | 28 | Female | 1 | 484 | na | K101E, E138A | 40 | 40 | AliveOnART | 3TC/TDF/DTG | 31.10.2019 |
27 | 19.06.2015 | 45 | Female | 4 | 179 | na | K103N, A98G | na | na | Defaulted | 3TC/TDF/EFV | 22.05.2016 |